Krajina: Nový Zéland
Jazyk: angličtina
Zdroj: Medsafe (Medicines Safety Authority)
Cilastatin sodium 571mg equivalent to 500 mg cilastatin acid. (Includes 4.6% overage).; Imipenem monohydrate 560mg equivalent to 500 mg Imipenem. (Includes 4.6% overage).;
Merck Sharp & Dohme (New Zealand) Limited
Cilastatin sodium 571 mg (=500 mg cilastatin acid. (Includes 4.6% overage).)
500mg/500mg
Powder for infusion
Active: Cilastatin sodium 571mg equivalent to 500 mg cilastatin acid. (Includes 4.6% overage). Imipenem monohydrate 560mg equivalent to 500 mg Imipenem. (Includes 4.6% overage). Excipient: Sodium bicarbonate
Vial, glass, 1x13ml =1dose unit, 13 mL
Prescription
Prescription
Merck Sharp & Dohme Corp
Package - Contents - Shelf Life: Vial, glass, 500mg/500mg - 1 dose units - 24 months from date of manufacture stored at or below 25°C 4 hours reconstituted stored at or below 25°C 24 hours reconstituted stored at 2° to 8°C (Refrigerate, do not freeze)
1986-05-15
PRIMAXIN ® _imipenem/cilastatin sodium_ 500 mg/500 mg Vial for injection WHAT IS IN THIS LEAFLET This leaflet answers some common questions about PRIMAXIN. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you using PRIMAXIN against the benefits he or she expects it will have for you. If you have any concerns about being given this medicine, ask your doctor or pharmacist. Keep this leaflet. You may need to read it again. WHAT PRIMAXIN IS USED FOR PRIMAXIN is an antibiotic which is used to treat serious infections caused by bacteria (germs). These infections may occur in many different parts of the body. PRIMAXIN is sometimes given in addition to other antibiotics. PRIMAXIN works by killing the bacteria causing the infection. BEFORE YOU ARE GIVEN PRIMAXIN WHEN YOU MUST NOT BE GIVEN IT Do not use PRIMAXIN if you have an allergy to PRIMAXIN or any of the ingredients listed at the end of this leaflet. BEFORE YOU ARE GIVEN IT Your doctor must know about all of the following before you are given PRIMAXIN, if you have or have had: • any allergies to other antibiotics, in particular, penicillins and cephalosporins • allergies to any other substances, such as foods, preservatives, or dyes If you have any of these allergies you may be allergic to PRIMAXIN. • a history of seizures or fits, or brain disease • kidney disease or urinary problems • any other medical conditions, including problems with your bowels Tell your doctor if you are taking a medicine containing valproic acid. If you are pregnant or are breast-feeding your doctor will discuss the possible risks and benefits of using PRIMAXIN during pregnancy and breast-feeding. PRIMAXIN passes into breast milk. Some medicines may affect the way other medicines work, and some should not be used together at all as they may harm people. If you have not told your doctor about any of the above, tell them before you are giv Prečítajte si celý dokument
1 NAME OF MEDICINE PRIMAXIN ® _imipenem/cilastatin_ 500 mg /500 mg injection PRESENTATION PRIMAXIN for intravenous use is supplied as a white sterile powder in 13 mL vials. Each vial contains 500 mg of imipenem equivalent and 500 mg cilastatin equivalent. The reconstituted solution is clear (however variations in colour from colourless to yellow do not affect the potency of the product). Note: PRIMAXIN for intramuscular use is not available in New Zealand. THERAPEUTIC CLASS Cilastatin is a competitive, reversible and specific inhibitor of dehydropeptidase-I enzyme. INDICATIONS The activity of PRIMAXIN against an unusually broad spectrum of pathogens makes it particularly useful in the treatment of polymicrobic mixed aerobic/anaerobic infections as well as initial therapy prior to the identification of the causative organisms. PRIMAXIN is indicated for the treatment of the following infections due to susceptible organisms: • Intra-abdominal infections • Lower respiratory tract infections • Gynaecological infections • Septicaemia • Genitourinary tract infections • Bone and joint infections • Skin and soft tissue infections • Endocarditis PRIMAXIN is indicated for the treatment of mixed infections caused by susceptible strains of aerobic and anaerobic bacteria. The majority of these mixed infections are associated with contamination by faecal flora or flora originating from the vagina, skin and mouth. In these mixed infections, _Bacteroides fragilis _is the most commonly encountered anaerobic pathogen and is usually resistant to aminoglycosides, cephalosporins and penicillins. However, _Bacteroides fragilis _is usually susceptible to PRIMAXIN. PRIMAXIN has demonstrated efficacy against many infections caused by aerobic and anaerobic gram-positive and gram-negative bacteria resistant to the cephalosporins, including cefazolin, cefoperazone, cephalothin, cefoxitin, cefotaxime, moxalactam, cefamandole, ceftazidime and ceftriaxone. Similarly, many infections caused by organisms resistant to aminoglycosi Prečítajte si celý dokument